Experienced Oncology CRO & Hematology CRO
A deep bench of knowledge that pairs oncology development expertise with wide-ranging rare disease experience in the largest areas of unmet need, including new treatments in cell and gene therapies and immuno-oncology.
The tireless pursuit of novel oncology treatments
The new course of cancer therapy
Precision medicine – devising patient-specific treatments to combat diseases once considered incurable – is radically changing the way the world looks at cancer therapy. The leaders in this field are small biotech and specialty pharmaceutical companies – organizations sometimes no larger than a few people and a single molecule. Our clinical trial expertise helps you get from brilliant idea to life-changing reality.
Why choose Premier?
- More than 170 hematology and oncology clinical trials completed through every phase, including multiple rare cancer and cell and gene therapy studies
- Expertise ranging from small dose-finding studies to large multinational trials
- Every aspect, from trial design and investigators to sites and patient selection, customized for your indication – including preferential regulatory pathways and other strategies for successful early planning and engagement
Precision cancer drugs
For the full potential of precision medicine to be realized, regulatory, technical, clinical, and economic frameworks will need to evolve to the nuances of these novel treatments.
Finding the fast track
Sponsors of first-in-human trials of novel oncology compounds face significant challenges. Track a hypothetical drug through its development paces, exploring the many aspects you must consider when performing early-stage oncology research.